Qube Research & Technologies (QRT)
BOLT icon

Qube Research & Technologies (QRT)’s Bolt Biotherapeutics BOLT Stock Holding History

Qube Research & Technologies (QRT)’s Portfolio BOLT Stock Details BOLT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Hold
0
– -$2 – 3351
2024
Q2 		– Hold
0
– – – 3685
2024
Q1 		– Hold
0
– – – 4345
2023
Q4 		– Hold
0
– – – 4239
2023
Q3 		– Hold
0
– – – 4005
2022
Q4 		– Sell
-964
Closed -$29K – 2496
2022
Q3 		$29K Sell
964
-60
-6% -$2.48K ﹤0.01% 2238
2022
Q2 		$42K Buy
1,024
+43
+4% +$1.67K ﹤0.01% 2157
2022
Q1 		$54K Sell
981
-1,301
-57% -$87.6K ﹤0.01% 2172
2021
Q4 		$224K Buy
2,282
+1,532
+204% +$291K ﹤0.01% 1927
2021
Q3 		$190K Buy
+750
New +$212K ﹤0.01% 1672

Other funds holding BOLT

TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $2.63B AUM 117.41% 1-Year Est. Return
PBPIA
Pivotal bioVenture Partners Investment Advisor San Francisco, California $280M AUM 181.4% 1-Year Est. Return
NFGH
Nan Fung Group Holdings Kai Tak, Hong Kong $121M AUM 56.89% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SB
Samsara BioCapital Palo Alto, California $1.03B AUM 214.94% 1-Year Est. Return
BOTOTLSJU
Board of Trustees of The Leland Stanford Junior University Redwood City, California $849M AUM 55.45% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
NM
Newtyn Management New York $936M AUM 27.23% 1-Year Est. Return

Qube Research & Technologies (QRT)'s BOLT Position: Q3 2024 in Review

Qube Research & Technologies (QRT) held its Bolt Biotherapeutics (BOLT) position steady in Q3 2024 at 0 shares worth $0. The position accounts for ﹤0.01% of the portfolio, ranked #3351.

Qube Research & Technologies (QRT) first reported a position in BOLT in Q3 2021 and has held it in 5 quarters since. The position peaked at $224K in Q4 2021. 32 funds tracked by Wall St. Rank hold BOLT as of Q3 2024.

  • Qube Research & Technologies (QRT) held 0 shares of Bolt Biotherapeutics worth $0 as of Q3 2024.
  • Qube Research & Technologies (QRT) left its Bolt Biotherapeutics share count unchanged in Q3 2024.
  • Bolt Biotherapeutics made up ﹤0.01% of Qube Research & Technologies (QRT)'s portfolio in Q3 2024, its #3351 holding.
  • Qube Research & Technologies (QRT) first reported a position in Bolt Biotherapeutics in Q3 2021 and has held it in 5 quarters since.
  • Qube Research & Technologies (QRT)'s Bolt Biotherapeutics position peaked at $224K in Q4 2021.
  • 32 funds tracked by Wall St. Rank held Bolt Biotherapeutics as of Q3 2024.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q3 2024, filed 14 Nov 2024.